[1] Rodríquez-Roisin R, Krowka MJ, Hervé P, el al. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J, 2004, 24: 861- 880.
[2] Krowka MJ, Fallon MB, Kawut SM, el al. International liver transplant society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension. Transplantation, 2016, 100: 1440-1452.
[3] Kennedy TC,Knudson RJ. Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis. Chest, 1977, 72:305-309.
[4] Zhang XJ, Katsuta Y, Akimoto T, el al. Intrapulmonary vascular dilatation and nitric oxide in hypoxemic rats with chronic bile duct ligation. J Hepatol, 2003, 39: 724-730.
[5] Zhang J, Yang W, Luo B, el al. The role of CX CL1/CX CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome. J Hepatol, 2012, 57: 752-758.
[6] Rolla G, Brussino L, Colagrande P, et al. Exhaled nitric oxide and impaired oxygenation in cirrhosis patients before and after liver transplantation. Ann InternMed, 1998, 129: 375-378.
[7] Rodriguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome-a liver-induced lung vascular disorder. N Engl J Med, 2008, 358: 2378-2387.
[8] Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology, 2005, 41: 1122-1129.
[9] Goldberg DS, Krok K, Batra S, el al. Impact of the hepatopulmonary syndrome MELD exception policy on outcomes of patients after liver transplantation: an analysis of the UNOS database. Gastroenterology, 2014, 146: 1256-1265.
[10] Grace JA, Angus PW. Hepatopulmonary syndrome: update on recent advances in pathophysiology, investigation, and treatment. J Gastroenterol Hepatol, 2013, 28: 213-219.
[11] Raevens S, Geerts A, Van Steenkiste C, el al. Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment. Liver Int, 2015, 35: 1646-1660.
[12] Arguedas MR, Singh H, Faulk DK. Utility of pulse oximetry screening for hepatopulmonary syndrome. Clin Gastroenterol Hepatol, 2007, 5: 749-754.
[13] Cheng TO. Mechanisms of platypnea-orthodeoxia: what causes water to flow uphill. Circulation, 2002, 105: e47.
[14] Saad NE, Lee DE, Waldman DL. Pulmonary arterial coil embolization for the management of persistent type I hepatopulmonary syndrome after liver transplantation. J Vasc Interv Radiol, 2007, 18: 1576-1580.
[15] DuBrock HM, Krowka MJ, Forde KA, et al. Clinical impact of intrapulmonary vascular dilatation in candidates for liver transplant. Chest, 2017, 5: 32873-32878.
[16] Fragaki M, Sifaki-Pistolla D, Samonakis DN, et al. Screening for hepatopulmonary syndrome in cirrhotic patients using technetium 99m-macroaggregated albumin perfusion lung scan(Tc-MAA): diagnostic approach and clinical correlations. J Clin Gastroenterol, 2017, 28.
[17] El-Shabrawi MH, Omran S, Wageeh S, et al. (99m)Technetium-macroaggregated albumin perfusion lung scan versus contrast enhanced echocardiography in the diagnosis of the hepatopulmonary syndrome in children with chronic liver disease. Eur J Gastroenterol Hepatol, 2010, 22: 1006-1012.
[18] Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med, 2011, 184:602-615.
[19] Fukushima KY, Yatsuhashi H, Kinoshita A, et al. Two cases of hepatopulmonary syndrome with improved liver function following long-term oxygen therapy. J Gastroenterol, 2007, 42: 176-180.
[20] Martinez-Palli G, Drake BB, Garcia-Pagan JC, et al. Effect of transjugular intrahepatic portosystemic shunt on pulmonary gas exchange in patients with portal hypertension and hepatopulmonary syndrome. World J Gastroenterol, 2005, 11: 6858-6862.
[21] Miyamoto A, Katsuta Y, Zhang XJ, et al. Effect of chronic methylene blue administration on hypoxemia in rats with common bile duct ligation. Hepatol Res, 2010, 40: 622-632.
[22] Rodríquez-Roisin R, Krowka MJ, Hervé P. Highlights of the ERS Task Force on pulmonary-hepatic vascular disorders (PHD). J Hepatol, 2005, 42: 924-927.
[23] Iyer VN, Swanson KL, Cartin-Ceba R, et al. Hepatopulmonary syndrome: favorable outcomes in the MELD exception era.Hepatology, 2013, 57: 2427-2435. |
